CN102188360B - 水蛭用于改善黑眼圈或眼袋的应用、组合物及其制备方法 - Google Patents
水蛭用于改善黑眼圈或眼袋的应用、组合物及其制备方法 Download PDFInfo
- Publication number
- CN102188360B CN102188360B CN2011101068987A CN201110106898A CN102188360B CN 102188360 B CN102188360 B CN 102188360B CN 2011101068987 A CN2011101068987 A CN 2011101068987A CN 201110106898 A CN201110106898 A CN 201110106898A CN 102188360 B CN102188360 B CN 102188360B
- Authority
- CN
- China
- Prior art keywords
- extract
- eye
- hirudo
- poria
- dispel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 241000545744 Hirudinea Species 0.000 title abstract 9
- 239000000284 extract Substances 0.000 claims abstract description 98
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims abstract description 34
- 102000007625 Hirudins Human genes 0.000 claims abstract description 32
- 108010007267 Hirudins Proteins 0.000 claims abstract description 32
- 229940006607 hirudin Drugs 0.000 claims abstract description 32
- 239000002537 cosmetic Substances 0.000 claims abstract description 17
- 241000237903 Hirudo Species 0.000 claims description 80
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 47
- 235000002673 Dioscorea communis Nutrition 0.000 claims description 41
- 241000544230 Dioscorea communis Species 0.000 claims description 41
- 208000035753 Periorbital contusion Diseases 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 37
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 34
- 210000000582 semen Anatomy 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 28
- OTQCKZUSUGYWBD-BRHMIFOHSA-N lepirudin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)[C@@H](C)O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C1=CC=C(O)C=C1 OTQCKZUSUGYWBD-BRHMIFOHSA-N 0.000 claims description 25
- 229960004408 lepirudin Drugs 0.000 claims description 25
- 239000012467 final product Substances 0.000 claims description 20
- 239000012567 medical material Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 10
- 239000002002 slurry Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 5
- 235000011613 Pinus brutia Nutrition 0.000 claims description 5
- 241000018646 Pinus brutia Species 0.000 claims description 5
- 238000003811 acetone extraction Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 34
- 239000002994 raw material Substances 0.000 abstract description 9
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 244000293323 Cosmos caudatus Species 0.000 description 23
- 235000005956 Cosmos caudatus Nutrition 0.000 description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 11
- 238000003756 stirring Methods 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 230000008092 positive effect Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 4
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 4
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000005571 anion exchange chromatography Methods 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 101710084517 Hementerin Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000237678 Hirudinidae Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 241000500851 Poecilobdella manillensis Species 0.000 description 1
- 101000993312 Poecilobdella manillensis Hirudin-HM2 Proteins 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 101000712605 Theromyzon tessulatum Theromin Proteins 0.000 description 1
- 229940122388 Thrombin inhibitor Drugs 0.000 description 1
- 241000964941 Whitmania Species 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 108010073977 decorsin Proteins 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003868 thrombin inhibitor Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
序号 | 珍珠粉% | 决明子提取物% | 茯苓提取物% | 黑眼圈祛除效果 | 眼袋祛除效果 |
1 | 1 | \ | \ | (++) | (++) |
2 | \ | 1 | \ | (+) | (+) |
3 | \ | \ | 1 | (+) | (+) |
4 | 1 | 1 | \ | (++) | (++) |
5 | 1 | 1 | 1 | (++) | (++) |
6 | 2 | \ | \ | (++) | (++) |
7 | \ | 2 | \ | (+) | (+) |
8 | \ | \ | 2 | (+) | (+) |
9 | 2 | 2 | \ | (+++) | (++) |
10 | 2 | 2 | 2 | (+++) | (++) |
11 | 3 | \ | \ | (+++) | (++) |
12 | \ | 3 | \ | (++) | (++) |
13 | \ | \ | 3 | (++) | (++) |
14 | 3 | 3 | \ | (+++) | (++) |
15 | 3 | 3 | 3 | (+++) | (++) |
16 | 4 | \ | \ | (+++) | (++) |
17 | \ | 4 | \ | (++) | (++) |
18 | \ | \ | 4 | (++) | (++) |
19 | 4 | 4 | \ | (+++) | (++) |
20 | 4 | 4 | 4 | (+++) | (++) |
21 | 5 | \ | \ | (+++) | (++) |
22 | \ | 5 | \ | (++) | (+++) |
23 | \ | \ | 5 | (++) | (+++) |
24 | 5 | 5 | \ | (+++) | (++) |
25 | 5 | 5 | 5 | (+++) | (+++) |
26 | 6 | \ | \ | (++) | (++) |
27 | \ | 6 | \ | (++) | (++) |
28 | \ | \ | 6 | (++) | (++) |
29 | 6 | 6 | \ | (++) | (++) |
30 | 6 | 6 | 6 | (++) | (+++) |
序号 | 药物 | 浓度(%) | 黑眼圈祛除效果 | 眼袋祛除效果 |
1. | 水蛭提取物+珍珠粉+决明子+茯苓 | 25+5+5+5 | (+++) | (+++) |
2. | 水蛭提取物+珍珠粉+决明子+茯苓 | 25+5+3+3 | (++) | (++) |
3. | 水蛭提取物+珍珠粉+决明子+茯苓 | 15+3+3+3 | (++) | (++) |
4. | 天然水蛭素+珍珠粉+决明子+茯苓 | 25+3+5+5 | (+++) | (+++) |
5. | 天然水蛭素+珍珠粉+决明子+茯苓 | 15+1+3+3 | (++) | (++) |
6. | 天然水蛭素+珍珠粉+决明子+茯苓 | 10+1+3+3 | (++) | (++) |
7. | 重组水蛭素+珍珠粉+决明子+茯苓 | 25+2+4+4 | (+++) | (+++) |
8. | 重组水蛭素+珍珠粉+决明子+茯苓 | 15+1+4+3 | (++) | (++) |
9. | 重组水蛭素+珍珠粉+决明子+茯苓 | 10+1+3+5 | (++) | (++) |
组分 | 质量% |
水蛭提取物 | 15 |
Carbopo 1940 | 1.0 |
丙二醇 | 16.0 |
辛酰基羟化小麦蛋白 | 8.0 |
去离子水 | 余量 |
组分 | 质量% |
重组水蛭素 | 10 |
霍霍巴油 | 60 |
芦荟油 | 25 |
抗氧剂、香精 | 适量 |
组分 | 质量% |
重组水蛭素 | 10 |
珍珠粉 | 4 |
决明子提取物 | 4 |
羟丙基纤维素 | 4 |
甘油 | 25 |
羟苯乙酯 | 1.2 |
纯化水 | 余量 |
组分 | 质量% |
天然水蛭素 | 15 |
珍珠粉 | 1 |
决明子提取物 | 3 |
茯苓提取物 | 3 |
海藻酸钠 | 5 |
壳聚糖 | 2 |
甘油 | 18 |
羟苯乙酯 | 1.2 |
纯化水 | 余量 |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101068987A CN102188360B (zh) | 2011-04-27 | 2011-04-27 | 水蛭用于改善黑眼圈或眼袋的应用、组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101068987A CN102188360B (zh) | 2011-04-27 | 2011-04-27 | 水蛭用于改善黑眼圈或眼袋的应用、组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102188360A CN102188360A (zh) | 2011-09-21 |
CN102188360B true CN102188360B (zh) | 2012-06-06 |
Family
ID=44597802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101068987A Active CN102188360B (zh) | 2011-04-27 | 2011-04-27 | 水蛭用于改善黑眼圈或眼袋的应用、组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102188360B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103330674A (zh) * | 2013-07-12 | 2013-10-02 | 梁家贵 | 一种富硒黄瓜蛋清眼膜 |
CN104921870A (zh) * | 2015-04-29 | 2015-09-23 | 周小尹 | 一种预防和治疗各种眼病的中药眼罩 |
CN107854326A (zh) * | 2017-12-19 | 2018-03-30 | 乳山寰海生物科技有限公司 | 一种水蛭素润颜保湿修护精华液 |
CN110711157A (zh) * | 2018-07-13 | 2020-01-21 | 迈健医药科技无锡有限公司 | 一种去黑眼圈的眼霜及其制备方法 |
CN108703927A (zh) * | 2018-07-25 | 2018-10-26 | 宁波博睿修存生物科技有限公司 | 修护眼霜 |
CN110639010A (zh) * | 2019-11-15 | 2020-01-03 | 云山化妆品研究开发(广州)有限公司 | 适用于眼部的含有重组水蛭素中药组合物及制备方法 |
CN112190507A (zh) * | 2020-10-28 | 2021-01-08 | 广州品赫化妆品有限公司 | 一种含有茯苓提取物的祛黑眼圈抗皱组合物及其制备方法、应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1522689A (zh) * | 2003-09-12 | 2004-08-25 | 周维海 | 水蛭提取物美容化妆品及其制备方法 |
CN1732897A (zh) * | 2005-08-16 | 2006-02-15 | 周维海 | 水蛭提取物美容护肤液及其制备方法 |
-
2011
- 2011-04-27 CN CN2011101068987A patent/CN102188360B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1522689A (zh) * | 2003-09-12 | 2004-08-25 | 周维海 | 水蛭提取物美容化妆品及其制备方法 |
CN1732897A (zh) * | 2005-08-16 | 2006-02-15 | 周维海 | 水蛭提取物美容护肤液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102188360A (zh) | 2011-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102188360B (zh) | 水蛭用于改善黑眼圈或眼袋的应用、组合物及其制备方法 | |
CN105287284B (zh) | 一种婴幼儿用含有艾叶提取物的沐浴露 | |
US20200170931A1 (en) | Soothing cream and manufacturing method thereof | |
CN105411951B (zh) | 黑柄炭角菌提取物在美白保湿化妆品中的应用 | |
CN106420459B (zh) | 一种人参水活精华液及其制备方法与包含其的面膜 | |
CN102178635B (zh) | 水蛭用于清洁皮肤的应用、皮肤清洁组合物及其制备方法 | |
JP2004346045A (ja) | 海洋深層水を使用する酒造時に得られる酒粕抽出エキスを有効成分とする化粧料添加剤、入浴剤及び健康食品類 | |
CN101829042B (zh) | 一种抗皮肤衰老的中药面膜及其制备方法 | |
CN113116801B (zh) | 一种用于改善皮肤亚健康状态的组合物及其制备方法 | |
CN102188359B (zh) | 水蛭用于护理头部毛发或头皮的用途、组合物及制备方法 | |
CN105232402B (zh) | 一种具有护肤功效的组合物 | |
CN105213270A (zh) | 美白祛斑组合物 | |
CN108186440A (zh) | 可抗菌护肤的中药植物沐浴露及其制备方法和用途 | |
CN103845450A (zh) | 山楂在制备治疗高尿酸血症、痛风、肾功能不全药物中的应用 | |
CN106214622A (zh) | 保湿修护爽肤水及其制备方法 | |
CN105410246A (zh) | 毛冬青黑茶及其制备方法 | |
CN105709209A (zh) | 一种治疗肿瘤的药物及其制备方法 | |
WO2019233158A1 (zh) | 中药凝胶组合物及其制备方法和用途 | |
JP2007063206A (ja) | 中性脂肪蓄積抑制剤 | |
US20230042135A1 (en) | Herbal shampoo composition and method for preparing the same | |
JP4488705B2 (ja) | 細胞賦活剤、ヒアルロン酸産生促進剤、デコリン産生促進剤、抗酸化剤、及び皮膚外用剤 | |
CN105246497A (zh) | 包含炮制提取物的组合物 | |
CN108938522B (zh) | 一种含有peg-12单月桂酸酯的卸妆乳及其制备方法 | |
JP4488706B2 (ja) | 中性脂肪蓄積抑制剤、痩身用皮膚外用剤、及び痩身用食品 | |
CN108159198A (zh) | 一种皮肤湿疹外用制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: CHONGQING DUOPUTAI PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: CHONGQING SHIZHENGE PUSHENG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Cao Jia Dian 400800 Chongqing city Wansheng District East Qingxi Bridge Patentee after: CHONGQING DUOPUTAI PHARMACEUTICAL Co.,Ltd. Address before: Cao Jia Dian 400800 Chongqing city Wansheng District East Qingxi Bridge Patentee before: Chongqing Duoputai Pharmaceutical Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP03 | Change of name, title or address |
Address after: Cao Jia Dian 400800 Chongqing city Wansheng District East Qingxi Bridge Patentee after: CHONGQING DUOPUTAI PHARMACEUTICAL Co.,Ltd. Address before: Cao Jia Dian 400802 Chongqing city Wansheng District Chongqing Donglin Qingxi bridge shizhenge Epson Pharmaceutical Co. Ltd. Patentee before: CHONGQING SHIZHENGE PUSHENG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240103 Address after: No. 303-7, Qingxi Bridge, Donglin Street, Wansheng Economic Development Zone, Qijiang District, Chongqing, 400800 Patentee after: Chongqing Duoputai Pharmaceutical Technology Co.,Ltd. Address before: 400800 Donglin Qingxi bridge in Wansheng District, Chongqing Patentee before: CHONGQING DUOPUTAI PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |